Who owns SILVERBACK THERAPEUTICS?
- Ticker: SBTX
- CUSIP Number: 82835w108
Tip: Access positions for across all investors
Analyze quarterly positions in Silverback Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Silverback Therapeutics stock
Who bought or sold SILVERBACK THERAPEUTICS this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
---|---|---|---|---|---|---|
OrbiMed Advisors | 8.7M | $31M | 0% | Mar 2022 | ||
FMR | 3.8M | $13M | 100% | Mar 2022 | ||
Daniel D. Thurber | 3.0M | $10M | 68% | Mar 2022 | ||
Nextech Invest | 1.9M | $6.7M | 0% | Mar 2022 | ||
Nantahala Capital Management | 914k | $3.2M | -9% | Mar 2022 | ||
Vanguard Group | 823k | $2.9M | 100% | Mar 2022 | ||
Renaissance Technologies | 671k | $2.4M | 82% | Mar 2022 | ||
Two Sigma Investments | 401k | $1.4M | 2% | Mar 2022 | ||
Morgan Stanley | 386k | $1.4M | 100% | Mar 2022 | ||
Two Sigma Advisers | 371k | $1.3M | 64% | Mar 2022 | ||
Geode Capital Management | 363k | $1.3M | -8% | Mar 2022 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Silverback Therapeutics? |
||||||
Ensign Peak Advisors | 346k | $1.2M | -16% | Mar 2022 | ||
State Street Corporation | 344k | $1.2M | 6% | Mar 2022 | ||
EcoR1 Capital | 330k | $1.2M | -69% | Mar 2022 | ||
Prosight Management | 325k | $1.1M | 505% | Mar 2022 | ||
T. Rowe Price Associates | 301k | $1.1M | 0% | Mar 2022 | ||
Silverarc Capital Management | 209k | $887k | 100% | Jun 2022 | ||
Citadel Advisors | 195k | $685k | 109% | Mar 2022 | ||
D. E. Shaw & Co | 187k | $658k | -25% | Mar 2022 | ||
Northern Trust | 174k | $609k | -3% | Mar 2022 | ||
Schroder Investment Management Group | 152k | $534k | -6% | Mar 2022 | ||
Charles Schwab Investment Management | 147k | $518k | -1% | Mar 2022 | ||
IndexIQ Advisors | 114k | $398k | 100% | Mar 2022 | ||
Bridgeway Capital Management | 103k | $360k | 100% | Mar 2022 | ||
Goldman Sachs Group | 102k | $356k | 30% | Mar 2022 | ||
Ohio Pers | 96k | $337k | 119% | Mar 2022 | ||
Belvedere Trading | 95k | $407k | 100% | Jun 2022 | ||
Janney Montgomery Scott | 85k | $297k | 0% | Mar 2022 | ||
Woodline Partners | 84k | $293k | -83% | Mar 2022 | ||
Privium Fund Management | 66k | $279k | 100% | Jun 2022 | ||
Nuveen Asset Management | 65k | $272k | 2% | Mar 2022 | ||
Bank of New York Mellon | 59k | $206k | -2% | Mar 2022 | ||
Susquehanna International | 41k | $145k | -32% | Mar 2022 | ||
Acadian Asset Management | 40k | $139k | -49% | Mar 2022 | ||
Occudo Quantitative Strategies | 36k | $128k | -38% | Mar 2022 | ||
Cubist Systematic Strategies | 36k | $127k | -19% | Mar 2022 | ||
Springbok Capital Management | 34k | $119k | 104% | Mar 2022 | ||
Honkamp Krueger Financial Services | 32k | $136k | 0% | Jun 2022 | ||
Marquette Asset Management | 31k | $132k | 100% | Jun 2022 | ||
Schonfeld Strategic Advisors | 29k | $100k | 100% | Mar 2022 | ||
Rhumbline Advisers | 24k | $85k | 13% | Mar 2022 | ||
New York Life Investments Alternatives | 24k | $84k | 100% | Mar 2022 | ||
GSA Capital Partners | 23k | $80k | 98% | Mar 2022 | ||
XTX Topco | 22k | $78k | 18% | Mar 2022 | ||
Parametric Portfolio Associates | 22k | $76k | -46% | Mar 2022 | ||
Tower Research Capital | 20k | $70k | 609% | Mar 2022 | ||
Barclays | 17k | $60k | 100% | Mar 2022 | ||
Jpmorgan Chase & Co | 14k | $50k | -92% | Mar 2022 | ||
Quattro Financial Advisors | 13k | $45k | 0% | Mar 2022 | ||
Deutsche Bank Aktiengesellschaft | 11k | $39k | -11% | Mar 2022 | ||
AQR Capital Management | 11k | $38k | 100% | Mar 2022 | ||
Etf Managers | 11k | $37k | 0% | Mar 2022 | ||
American International | 10k | $36k | -7% | Mar 2022 | ||
California State Teachers Retirement System | 9.0k | $32k | -19% | Mar 2022 | ||
Russell Investments | 8.4k | $35k | 100% | Jun 2022 | ||
Quantbot Technologies | 5.4k | $19k | -32% | Mar 2022 | ||
Wells Fargo & Company | 4.2k | $13k | -51% | Mar 2022 | ||
NISA Investment Advisors | 4.1k | $14k | 100% | Mar 2022 | ||
Amalgamated Bank | 2.5k | $9.0k | 100% | Mar 2022 | ||
Legal & General Group | 1.6k | $6.0k | 0% | Mar 2022 | ||
Summit Investment Advisors | 1.0k | $4.0k | 0% | Mar 2022 | ||
UBS Group | 513.00 | $2.9k | -99% | Mar 2022 | ||
Simplex Trading | 371.00 | $999.993400 | -83% | Mar 2022 | ||
Ellevest | 243.00 | $999.993600 | 100% | Jun 2022 | ||
Group One Trading | 200.00 | $1.0k | 100% | Mar 2022 | ||
New York State Common Retirement Fund | 169.00 | $1.0k | -99% | Jun 2022 | ||
Captrust Financial Advisors | 146.00 | $999.997800 | 100% | Mar 2022 | ||
S.A.C. Capital Advisors | 145.00 | $1.0k | 100% | Mar 2022 | ||
Toronto-Dominion Bank | 2.00 | $0 | 0% | Mar 2022 |
Who sold out of Silverback Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
RA Capital Management | Dec 2021 | 1.7M | $12M |
Endurant Capital Management | Dec 2021 | 84k | $561k |
Nomura Holdings | Dec 2021 | 69k | $461k |
Hrt Financial | Dec 2021 | 64k | $423k |
Jump Financial | Dec 2021 | 38k | $252k |
Trexquant Investment | Dec 2021 | 31k | $203k |
Bailard | Mar 2022 | 30k | $106k |
Bank of America Corporation | Dec 2021 | 24k | $158k |
HighVista Strategies | Dec 2021 | 22k | $149k |
Virtu Financial | Dec 2021 | 20k | $135k |
ExodusPoint Capital Management | Dec 2021 | 19k | $128k |
PDT Partners | Dec 2021 | 17k | $112k |
Board of Trustees of The Leland Stanford Junior University | Dec 2021 | 15k | $97k |
Hohimer Wealth Management | Mar 2022 | 12k | $42k |
EMC Capital Management | Dec 2021 | 7.2k | $48k |
Eagle Bay Advisors | Dec 2021 | 5.9k | $42k |
Us Bancorp | Dec 2021 | 1.8k | $12k |